Produkty 51938-32-0

CAS 51938-32-0 występuje w naszej ofercie pod nazwami: Schaftoside, Schaftoside/ 97%, Schaftoside, 99.70%, Schaftoside (Standard), Schaftoside, 10 mg. Oferty producentów: Chemat Brand, GLPBio, TargetMol, Biosynth, MedChemExpress. Dostępne opakowania: on request, 20mg, 1mg, 5mg, 10mg, 25mg, 50mg, 100mg.

Schaftoside
Chemat Brand, GLPBio, Biosynth
  • opakowanie: on request, 20mg, 25mg, 10mg
  • Warianty: 7
od 1678,24
Zobacz produkt
Schaftoside/ 97%
TargetMol
  • opakowanie: 1mg, 5mg, 10mg, 25mg
  • Warianty: 7
od 452,11
Zobacz produkt
Schaftoside, 99.70%
MedChemExpress
  • opakowanie: 10 mg, 1 mg, 25 mg, 50 mg
  • Warianty: 6
od 333,62
Zobacz produkt
Schaftoside (Standard)
MedChemExpress
  • opakowanie: 25 mg, 50 mg, 5 mg, 100 mg
  • Warianty: 5
od 1225,27
Zobacz produkt
Schaftoside, 10 mg
Roth
  • opakowanie: 10mg
  • Warianty: 1
od 844,81
Zobacz produkt
Schaftoside, 25 mg
Roth
  • opakowanie: 25mg
  • Warianty: 1
od 1694,34
Zobacz produkt
Schaftoside, 50 mg
Roth
  • opakowanie: 50mg
  • Warianty: 1
od 2855,36
Zobacz produkt
Schaftoside, 100 mg
Roth
  • opakowanie: 100mg
  • Warianty: 1
od 4837,60
Zobacz produkt
Schaftoside, 98%
Ambeed
  • opakowanie: 100mg, 250mg
  • Warianty: 2
od 2283,88
Zobacz produkt
5,7-Dihydroxy-2-(4-hydroxyphenyl)-6-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)-8-((2S,3R,4S,5S)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)-4H-chromen-4-one, 98%
Chemat, BLDpharm
  • opakowanie: 1mg, 5mg, 10mg, 25mg
  • Warianty: 13
od 141,20
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

5,7-dihydroxy-2-(4-hydroxyphenyl)-6-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-8-[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]chromen-4-one (CAS 51938-32-0) to związek chemiczny o wzorze sumarycznym C26H28O14 i masie molowej 564.5 g/mol. Nazwa systematyczna IUPAC: 5,7-dihydroxy-2-(4-hydroxyphenyl)-6-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-8-[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]chromen-4-one. InChIKey: MMDUKUSNQNWVET-VYUBKLCTSA-N.

Dane identyfikacyjne
Wzór sumarycznyC26H28O14
Masa molowa564.5 g/mol
Nazwa IUPAC5,7-dihydroxy-2-(4-hydroxyphenyl)-6-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-8-[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]chromen-4-one
InChIKeyMMDUKUSNQNWVET-VYUBKLCTSA-N
SMILESC1[C@@H]([C@@H]([C@H]([C@@H](O1)C2=C3C(=C(C(=C2O)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)C(=O)C=C(O3)C5=CC=C(C=C5)O)O)O)O

Dane obliczone przez PubChem (NCBI)

Synonimy: Schaftoside, Apigenin-6-glucoside-8-arabinoside, Shaftoside, Apigenin 6-C-glucoside-8-C-arabinoside, 6-C-beta-glucopyranosyl-8-C-alpha-arabinopyranosylapigenin, apigenin 6-C-beta-D-glucopyranosyl-8-C-alpha-L-arabinopyranoside, Schaftoside (Standard), orb1222125, orb1303590, orb3140741
Powiązane formy tego związku
5,7-dihydroxy-2-(4-hydroxyphenyl)-6-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-8-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]chromen-4-one C26H28O14
5,7-dihydroxy-2-(4-hydroxyphenyl)-6-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-8-[(2R,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]chromen-4-one C26H28O14
Izomery (ten sam wzór sumaryczny)
5,7-dihydroxy-2-(4-hydroxyphenyl)-8-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-6-[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]chromen-4-one C26H28O14
7-[(2S,3R,4S,5S,6R)-3-[(2S,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chromen-4-one C26H28O14
7-[(2S,3R,4S,5S,6R)-6-[[(2R,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl]oxy-5-hydroxy-3-(4-hydroxyphenyl)chromen-4-one C26H28O14
6-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]-5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one C26H28O14
5,7-dihydroxy-2-(4-hydroxyphenyl)-8-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-6-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]chromen-4-one C26H28O14
1-hydroxy-2-(hydroxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxyanthracene-9,10-dione C26H28O14
8-[(2S,3R,4R,5S,6R)-6-[[(2R,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl]-3-(3,4-dihydroxyphenyl)-7-hydroxychromen-4-one C26H28O14
7-hydroxy-2-(4-hydroxyphenyl)-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one C26H28O14
1,5-dihydroxy-2-methyl-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxyanthracene-9,10-dione C26H28O14
5,7-dihydroxy-2-(4-hydroxyphenyl)-8-[(2S,3R,4R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-6-[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]chromen-4-one C26H28O14